Appendix 3Y Change of Director's Interest Notice Appendix 3Y Change of Director's Interest Notice

Rule 3.19A.2

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity RESAPP HEALTH LIMITED

ABN 51 094 468 318

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director

Chris Ntoumenopoulos

Date of last notice

11 November 2016

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

Direct or indirect interest

Indirect

Nature of indirect interest (including registered holder)

Note: Provide details of the circumstances giving rise to the relevant interest.

Sobol Capital Pty Ltd - director, shareholder and beneficiary

Date of change

9 August 2017

No. of securities held prior to change

2,109,375 Shares

1,800,000 Director Incentive Options exercisable at $0.45; expiring 10 November 2019; and

1,800,000 Director Incentive Options exercisable at $0.75; expiring 10 November 2019

Class

Ordinary Fully Paid Shares

Number acquired

One million (1,000,000) Shares

Number disposed

Nil

Value/Consideration

Note: If consideration is non-cash, provide details and estimated valuation

$72,821.92

+ See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director's Interest Notice

No. of securities held after change

3,109,375 Shares

1,800,000 Director Incentive Options exercisable at $0.45; expiring 10 November 2019; and

1,800,000 Director Incentive Options exercisable at $0.75; expiring 10 November 2019

Nature of change

Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back

On Market Trade

Part 2 - Change of director's interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.

Detail of contract

Not applicable

Nature of interest

Not applicable

Name of registered holder (if issued securities)

Not applicable

Date of change

Not applicable

No. and class of securities to which interest related prior to change

Note: Details are only required for a contract in relation to which the interest has changed

Not applicable

Interest acquired

Not applicable

Interest disposed

Not applicable

Value/Consideration

Note: If consideration is non-cash, provide details and an estimated valuation

Not applicable

Interest after change

Not applicable

+ See chapter 19 for defined terms.

Appendix 3Y Page 2 01/01/2011

Part 3 - +Closed period Appendix 3Y Change of Director's Interest Notice

Were the interests in the securities or contracts detailed

above traded during a +closed period where prior written clearance was required?

Yes

If so, was prior written clearance provided to allow the trade to proceed during this period?

Yes

If prior written clearance was provided, on what date was this provided?

9 August 2017

+ See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3

ResApp Health Limited published this content on 11 August 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 10 August 2017 23:25:02 UTC.

Original documenthttps://www.resapphealth.com.au/wp-content/uploads/2017/08/1700334.pdf

Public permalinkhttp://www.publicnow.com/view/891E2EB60380902F7E6FE36DB5B1936A31BA316B